North America

Integra LifeSciences Completes Acquisition of Acclarent, Expands Market Reach in ENT Surgical Solutions

 Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, announced it has successfully completed it...

 April 02, 2024 | News

GE HealthCare Launches AI-Driven Prostate Volume Assist to Transform Urological Imaging

New AI software feature will be available for use on the bkActiv, bk3000/5000 and bkSpecto active imaging systems Addition of AI solution advances...

 March 28, 2024 | News

Hoth Therapeutics' Merveille.ai Achieves Breakthrough in Obesity Treatment with AI-Driven Therapeutic Candidate

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient focused biopharmaceutical company, is excited to announce a significant breakthrough by its sub...

 March 28, 2024 | News

EditCo Bio Launches with Acquisition of Synthego's Cell Engineering Divisions to Boost CRISPR Market Innovations

EditCo Bio, Inc. announced that it has launched its business with the acquisition of Synthego's engineered cell solutions and enhanced guide RNA business. ...

 March 28, 2024 | News

Integrated DNA Technologies Launches Innovative Custom Vector Onboarding Tool to Streamline Gene Synthesis

Integrated DNA Technologies (IDT), a global leader in genomics solutions, announced  the expansion of its gene synthesis services with the launch of a...

 March 28, 2024 | News

Enveric Biosciences Divests Cancer-Targeting Cannabinoid IP to Focus on Mental Health Therapeutics

  Enveric Biosciences (NASDAQ: ENVB), a pioneering biotechnology firm at the forefront of developing neuroplastogenic small-molecule therapeutics, an...

 February 26, 2024 | News

WuXi Advanced Therapies Receives FDA Approval to Manufacture Iovance's AMTAGVI™ (lifileucel) for Advanced Melanoma

       WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, today announced that the U.S. Food and Dr...

 February 21, 2024 | News

Gilead Sciences Bolsters Liver Portfolio Through Acquisition of CymaBay Therapeutics

    Gilead Sciences, Inc. and CymaBay Therapeutics, Inc. announced today a definitive agreement whereby Gilead will acquire CymaBay for $32.50 ...

 February 13, 2024 | News

AstraZeneca Boosts US Manufacturing to Accelerate Cell Therapy Advancements

AstraZeneca is investing $300 million in a state-of-the-art facility in Rockville, MD to launch its life-saving cell therapy platforms in the US for critic...

 February 07, 2024 | News

Genesis MedTech Finishes U.S. Study Enrollment for J-Valve™ in Severe Aortic Regurgitation

Genesis MedTech, a leading medical device company, today announced the completion of enrollment in its United States Early Feasibility Study (EFS) usi...

 February 06, 2024 | News

LabCorp Launches New Test for Severe Preeclampsia Risk in Pregnant Women

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services,  announced the launch and availability of a new, FDA-cle...

 February 01, 2024 | News

Amcor Expands Thermoforming Capacity for Healthcare Growth in North America

The addition of automated, state-of-the art thermoforming equipment at Amcor's world-class healthcare manufacturing plant in Oshkosh, Wisconsin w...

 February 01, 2024 | News

Allied Digestive Health and Provation Sign Agreement for Enhanced Patient Care

Allied Digestive Health (ADH), the beacon of cutting-edge gastroenterology (GI) services across New Jersey and New York, is joining forces with Provation, ...

 January 22, 2024 | News

Bora Pharmaceuticals Expands Globally with $210 Million Acquisition of Upsher-Smith

BioPharma APAC Perspective: Bora's acquisition of Upsher-Smith for $210 million marks a pivotal moment for the pharmaceutical giant. This strategic move n...

 January 18, 2024 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close